Potentiation of C1 inhibitor plus heparin in prevention of complement-mediated activation of endothelial cells in a model of xenograft hyperacute rejection.
DVA Medical Center, Minneapolis, MN 55417.
A P
AP
Dalmasso
J L
JL
Platt
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003167:Complement Activation; D003174:Complement C1 Inactivator Proteins / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D006084:Graft Rejection; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D008954:Models, Biological; D013552:Swine; D014183:Transplantation, Heterologous
D003174:Complement C1 Inactivator Proteins; D006493:Heparin